Mineralys Therapeutics Inc
MLYS13.030USD
-0.635-4.65%
Market hours （ET）Quotes delayed by 15 min
USD0.000Pre-market (ET)
845.34MMarket Cap
LossP/E TTM
Mineralys Therapeutics Inc
13.030
-0.635-4.65%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q2
FY2022Q1
FY2021Q4
Operating cash flows (indirect method)
Cash flow from continuing operating activities
-137.67%-45.49M
-130.64%-66.84M
-163.71%-50.19M
-47.88%-30.15M
-49.82%-19.14M
-184.52%-28.98M
---19.03M
-272.76%-20.39M
-94.21%-12.78M
-108.30%-10.19M
---5.47M
---6.58M
---4.89M
Net income from continuing operations
-33.97%-42.21M
-100.69%-48.95M
-147.55%-56.34M
-237.81%-41.01M
-149.90%-31.51M
-168.81%-24.39M
---22.76M
-87.39%-12.14M
-66.57%-12.61M
-28.10%-9.07M
---6.48M
---7.57M
---7.08M
Operating gains losses
87.50%15.00K
--15.00K
--11.00K
--9.00K
--8.00K
----
----
----
----
----
----
----
----
Other non-cash items
----
----
----
----
----
----
----
----
----
--0.00
----
----
--0.00
Change in working capital
-146.45%-5.89M
-394.83%-19.71M
39.02%5.72M
243.71%10.83M
20885.25%12.68M
-332.46%-3.98M
--4.11M
-866.16%-7.54M
-106.28%-61.00K
-142.31%-921.00K
--984.00K
--972.00K
--2.18M
-Change in prepaid expenses
-205.70%-4.40M
-156.38%-3.13M
190.91%2.73M
132.71%1.18M
344.22%4.16M
30.84%-1.22M
---3.00M
-7248.98%-3.60M
-1676.85%-1.70M
-1225.48%-1.77M
---49.00K
--108.00K
--157.00K
-Change in payables and accrued expense
-118.40%-1.55M
-444.72%-16.67M
-59.60%2.96M
351.11%9.47M
339.38%8.40M
-461.82%-3.06M
--7.34M
-465.15%-3.77M
121.30%1.91M
-58.12%846.00K
--1.03M
--864.00K
--2.02M
Cash from non-recurring investing activities
Cash from operating activities
-137.67%-45.49M
-130.64%-66.84M
-163.71%-50.19M
-47.88%-30.15M
-49.82%-19.14M
-184.52%-28.98M
---19.03M
-272.76%-20.39M
-94.21%-12.78M
-108.30%-10.19M
---5.47M
---6.58M
---4.89M
Investing cash flow
Net cash from continuing investing activities
-100.00%0.00
--0.00
--37.00K
--0.00
--59.00K
----
----
----
----
----
----
----
----
Capital expenditures
-100.00%0.00
--0.00
--37.00K
--0.00
--59.00K
----
----
----
----
----
----
----
----
Net cash flow from disposal of fixed assets
-100.00%0.00
--0.00
--37.00K
--0.00
--59.00K
----
----
----
----
----
----
----
----
Net cash flow from investment products
-66.17%-92.88M
1133.13%83.57M
1887.57%79.64M
147.93%7.74M
60.15%-55.89M
-116.18%-8.09M
--4.01M
---16.14M
---140.25M
--50.00M
--0.00
--0.00
----
Cash from non-current investing activities
Net cash flow from investing activities
-65.99%-92.88M
1133.13%83.57M
1886.65%79.61M
147.93%7.74M
60.11%-55.95M
-116.18%-8.09M
--4.01M
---16.14M
---140.25M
--50.00M
--0.00
--0.00
----
Financing cash flow
Cash flow from continuous financing activities
62.88%189.28M
21.62%90.00K
-100.54%-1.00K
73.84%-152.00K
-42.92%116.20M
106.93%74.00K
--184.00K
-100.49%-581.00K
1596.85%203.57M
---1.07M
--117.65M
--12.00M
--0.00
Net cash flow from debt Issuance/repayment
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
Net cash flow from common stock issuance/repurchase
62.91%189.17M
29.69%83.00K
--0.00
113.43%78.00K
-42.96%116.12M
--64.00K
--0.00
---581.00K
--203.57M
----
--0.00
--0.00
----
Net cash flow from preferred stock issuance/repurchase
----
----
----
----
----
--0.00
--0.00
-100.00%0.00
-100.00%0.00
--0.00
--117.65M
--12.00M
--0.00
Proceeds from stock option exercised by employees
-17.45%123.00K
440.00%54.00K
-78.26%40.00K
--54.00K
--149.00K
--10.00K
--184.00K
----
----
----
----
----
----
Net cash flow from other financing activities
84.13%-10.00K
---47.00K
---41.00K
---284.00K
---63.00K
----
----
----
----
---1.07M
----
----
----
Net cash from non-recurrent financing activities
Net cash from financing activities
62.88%189.28M
21.62%90.00K
-100.54%-1.00K
73.84%-152.00K
-42.92%116.20M
106.93%74.00K
--184.00K
-100.49%-581.00K
1596.85%203.57M
---1.07M
--117.65M
--12.00M
--0.00
Net cash flow
Beginning cash balance
131.40%114.09M
12.72%97.27M
-32.91%67.86M
-34.60%90.42M
-43.78%49.30M
76.28%86.30M
--101.14M
759.69%138.25M
722.56%87.70M
214.78%48.95M
--16.08M
--10.66M
--15.55M
Current period cash flow changes
23.84%50.92M
145.46%16.82M
298.23%29.42M
39.20%-22.56M
-18.66%41.11M
-195.48%-37.00M
---14.84M
-133.08%-37.11M
832.74%50.55M
892.35%38.75M
--112.18M
--5.42M
---4.89M
Ending cash balance
82.49%165.01M
131.40%114.09M
12.72%97.27M
-32.91%67.86M
-34.60%90.42M
-43.78%49.30M
--86.30M
-21.15%101.14M
759.69%138.25M
722.56%87.70M
--128.26M
--16.08M
--10.66M
Free cash flow
-136.94%-45.49M
-130.64%-66.84M
-163.90%-50.22M
-47.88%-30.15M
-50.28%-19.20M
-184.52%-28.98M
---19.03M
-272.76%-20.39M
-94.21%-12.78M
---10.19M
---5.47M
---6.58M
----
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
